Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 307 articles: HTML format

Single Articles

October 2026
1. GALLI M, Ten Berg J, Berry C
   Meta-analyses limitations and the compelling case for a contemporary, pragmatic trial of clopidogrel vs aspirin for secondary prevention of coronary heart disease: clopidogrel is not superior to aspirin in non-East Asian patients.
   Eur Heart J. 2026 Oct 10:ehag805. doi: 10.1093.
   PubMed    
   
   
   
2. MAHENDIRAN T, Corradetti S, Perera D, Pijls NHJ, et al
   Coronary autoregulation: the complex interplay between epicardial and microvascular resistance.
   Eur Heart J. 2026;47:5279-5292.
   PubMed     Abstract available
   
   
   September 2026
3. ARMSTRONG PW, Danays T, Westerhout CM
   Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction.
   Eur Heart J. 2026 Sep 21:ehag754. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. LI S, Wang W, Zhou H, Zhang Y, et al
   Tropical cyclones and acute coronary syndromes: a Chinese nationwide study.
   Eur Heart J. 2026;47:4826-4838.
   PubMed     Abstract available
   
   
   
5. MAY HT, Le VT, Anderson JL, Iverson L, et al
   Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.
   Eur Heart J. 2026 Sep 7:ehag611. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. DAVIS JW, Manson JE
   More is not always better: vitamin D supplementation post-myocardial infarction in the Target-D trial.
   Eur Heart J. 2026 Sep 7:ehag672. doi: 10.1093.
   PubMed    
   
   
   August 2026
7. VORA KP, Bhatt K, Doshi S, Poptani V, et al
   Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study.
   Eur Heart J. 2026 Aug 31:ehag715. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. TARANTINI G, Zhang X, Nai Fovino L, Kan J, et al
   One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials.
   Eur Heart J. 2026 Aug 29:ehag737. doi: 10.1093.
   PubMed    
   
   
   
9. WOOD DA, Jennings CS, Kotseva K, Adamska A, et al
   ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey.
   Eur Heart J. 2026 Aug 29:ehag741. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. SEPEHRI SHAMLOO A, Chiba T, Tijssen JGP, Althof T, et al
    Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study.
    Eur Heart J. 2026 Aug 28:ehag706. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. DE FERRARI GM, Giugliano RP, Leiter LA, Nicolau JC, et al
    Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
    Eur Heart J. 2026 Aug 28:ehag739. doi: 10.1093.
    PubMed    
    
    
    
12. MILLS NL, Newby LK, Zaman S, Almahmeed WA, et al
    Fifth Universal Definition of Myocardial Infarction (2026).
    Eur Heart J. 2026 Aug 28:ehag101. doi: 10.1093.
    PubMed    
    
    
    
13. BAI B, Cao L, Lin K, Luo C, et al
    Aerobic exercise attenuates peri-infarct fibrosis and improves fitness early after acute myocardial infarction: a randomized trial.
    Eur Heart J. 2026 Aug 26:ehag651. doi: 10.1093.
    PubMed    
    
    
    
14. HEUSCH G, Kleinbongard P, Gourine AV
    The vagus nerve in myocardial infarction.
    Eur Heart J. 2026 Aug 26:ehag674. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. NAIR A, van der Kaaij NP, Kluin J, Rogers J, et al
    Total artificial hearts: an evolution on the horizon.
    Eur Heart J. 2026;47:4396-4409.
    PubMed     Abstract available
    
    
    
16. MCCARTHY CP, Whelton H, McEvoy JW
    Periodontitis and coronary heart disease: inflamed gums, diseased arteries?
    Eur Heart J. 2026 Aug 21:ehag634. doi: 10.1093.
    PubMed    
    
    
    
17. PARGAONKAR VS, Schnittger I, Wong CCY, Wang H, et al
    Angina with non-obstructive coronary arteries and myocardial bridge: long-term outcomes of surgical unroofing.
    Eur Heart J. 2026;47:4290-4303.
    PubMed     Abstract available
    
    
    
18. LARSEN AF, Kuhl JT, Sigvardsen PE, Afzal S, et al
    Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.
    Eur Heart J. 2026 Aug 12:ehag612. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2026
19. PARKER SJ, Mao C, Caudell DL, Seals AL, et al
    Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences.
    Eur Heart J. 2026;47:3840-3856.
    PubMed     Abstract available
    
    
    
20. RAVEENDRA K, Gale CP
    Translating evidence of beta-blocker effectiveness following myocardial infarction.
    Eur Heart J. 2026 Jul 17:ehag506. doi: 10.1093.
    PubMed    
    
    
    June 2026
21. KANG J, Han M, Wang L
    Fulminant myocarditis complicated by acute myocardial infarction.
    Eur Heart J. 2026 Jun 23:ehag366. doi: 10.1093.
    PubMed    
    
    
    
22. PUELACHER C, Glarner N, Mueller C
    Despite uncertainty, cardiologist involvement in care of perioperative myocardial infarction/injury appears reasonable.
    Eur Heart J. 2026 Jun 19:ehag475. doi: 10.1093.
    PubMed    
    
    
    
23. GOVIND A
    Peri-operative myocardial infarction after non-cardiac surgery: validating the case for cardiologist involvement while acknowledging what remains unresolved.
    Eur Heart J. 2026 Jun 19:ehag473. doi: 10.1093.
    PubMed    
    
    
    
24. CREA F
    Ischaemic heart disease: focus on sex and gender differences, coronary pathophysiology, and remodelling after myocardial infarction.
    Eur Heart J. 2026;47:2711-2717.
    PubMed    
    
    
    
25. KAKIZAKI R, Biccire FG, Losdat S, Ueki Y, et al
    Silent plaque ruptures in non-obstructive lesions of non-infarct-related arteries: a multimodality, serial intracoronary imaging study.
    Eur Heart J. 2026;47:2814-2826.
    PubMed     Abstract available
    
    
    
26. MANFRINI O, Tousoulis D, Antoniades C, Badimon L, et al
    Sex and gender differences in coronary pathophysiology and ischaemic heart disease.
    Eur Heart J. 2026;47:2727-2749.
    PubMed     Abstract available
    
    
    
27. WEBB CM, Collins P
    Stable angina in young women.
    Eur Heart J. 2026;47:2766-2776.
    PubMed     Abstract available
    
    
    
28. ANDREOTTI F, Thiele H, Vrints C, Jobs A, et al
    Great debate: the new risk factor-weighted clinical likelihood model is useful to estimate the initial pre-test probability of obstructive coronary artery disease in individuals with suspected chronic coronary syndromes.
    Eur Heart J. 2026;47:2777-2792.
    PubMed     Abstract available
    
    
    
29. EIJSVOGELS TMH, Kim JH, Aengevaeren VL, D'Ascenzi F, et al
    Masters athletes with abnormal cardiovascular findings: a clinical consensus statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology.
    Eur Heart J. 2026;47:2541-2560.
    PubMed     Abstract available
    
    
    May 2026
30. CENKO E, Badimon L, Vadala G, Merkus D, et al
    Pathophysiology, prevention, and management of coronary microvascular obstruction.
    Eur Heart J. 2026 May 26:ehag334. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. KRISTENSEN AMD, Jortveit J, Holmager T, Atar D, et al
    Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.
    Eur Heart J. 2026 May 25:ehag348. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. JOHNSON TW, Gonzalo N, de la Torre Hernandez JM, Amabile N, et al
    Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC).
    Eur Heart J. 2026 May 15:ehag353. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. LORUSSO R, Matteucci M, Ronco D, Massimi G, et al
    Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction.
    Eur Heart J. 2026 May 11:ehag164. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. HOLMGREN L, von Koch S, Andell P, Sorensson P, et al
    Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease.
    Eur Heart J. 2026 May 11:ehag216. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. TEPPO K, Airaksinen KEJ, Wittfooth S
    Long cardiac troponin T in myocardial infarction: the SuperTROPO study is a promising starting point.
    Eur Heart J. 2026 May 7:ehag332. doi: 10.1093.
    PubMed    
    
    
    
36. MENG C, Wang Y, Miao G
    Long cardiac troponin T in myocardial infarction: a promising diagnostic tool, a precision imperative.
    Eur Heart J. 2026 May 7:ehag327. doi: 10.1093.
    PubMed    
    
    
    
37. CORTESE B, Mehilli J, Belmonte M, Wanha W, et al
    Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2026;47:2035-2043.
    PubMed     Abstract available
    
    
    
38. ALEXANDROU M, Sandoval Y, Alfonso F, Brilakis ES, et al
    Subacute coronary artery occlusion: complexities of the grey zone.
    Eur Heart J. 2026;47:2022-2034.
    PubMed     Abstract available
    
    
    
39. AZARBARZIN A, Vena D, Esmaeili N, Wellman A, et al
    Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis.
    Eur Heart J. 2026;47:2077-2089.
    PubMed     Abstract available
    
    
    April 2026
40. KRONBORG AH, Hasselbalch RB, Pedersen CHG, Knudsen SS, et al
    Macrotroponin I: association with suspected myocardial infarction with non-obstructive coronary artery.
    Eur Heart J. 2026 Apr 28:ehag312. doi: 10.1093.
    PubMed    
    
    
    
41. NURMOHAMED NS, Bhatt DL
    Bridging the gap in prevention of first myocardial infarction.
    Eur Heart J. 2026 Apr 24:ehag284. doi: 10.1093.
    PubMed    
    
    
    
42. SIMEON MJ
    Gaps in cardiovascular risk identification and preventive therapy before first myocardial infarction.
    Eur Heart J. 2026 Apr 24:ehag283. doi: 10.1093.
    PubMed    
    
    
    
43. ALCOVER S, Ramos-Regalado L, Munoz-Garcia N, Giron GO, et al
    Eicosapentaenoic acid ethyl ester, cardiac metabolomic and lipidomic signatures, and cardioprotection in myocardial infarction.
    Eur Heart J. 2026 Apr 17:ehag187. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. BHATT DL, Perrone Filardi P, Khan I, Tunon J, et al
    PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study.
    Eur Heart J. 2026 Apr 16:ehag176. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. OTERO S, Radike M, Ben-Aicha S, Mendieta G, et al
    Cardioprotection with intravenous statin administration during myocardial infarction vs. oral preloading: a preclinical study.
    Eur Heart J. 2026 Apr 15:ehag269. doi: 10.1093.
    PubMed    
    
    
    
46. GUIDA G, Disabato G, Piepoli M
    A natural experiment in the air: particulate matter and acute myocardial infarction subtypes during the COVID-19 pandemic.
    Eur Heart J. 2026 Apr 9:ehag218. doi: 10.1093.
    PubMed    
    
    
    
47. ROSSELLO X
    Age, frailty, and outcomes in myocardial infarction: a new paradigm for an old concept.
    Eur Heart J. 2026 Apr 9:ehag213. doi: 10.1093.
    PubMed    
    
    
    March 2026
48. NYEN JE, Kristensen AMD, Dammen T, Zwisler AD, et al
    Beta-blockers, depression, and anxiety after myocardial infarction: the BETAMI-DANBLOCK trial.
    Eur Heart J. 2026 Mar 25:ehag200. doi: 10.1093.
    PubMed    
    
    
    
49. QI Y, Li J, Yang Z, Liu J, et al
    Cardiovascular disease in China: epidemiological evolution and implications.
    Eur Heart J. 2026 Mar 25:ehaf1121. doi: 10.1093/eurheartj/ehaf1121.
    PubMed     Abstract available
    
    
    
50. METEVA D, Pedicino D, Abdelwahed YS, Krankel N, et al
    Acute coronary syndrome with plaque erosion: clinical characteristics, mechanisms, and unmet needs.
    Eur Heart J. 2026;47:1403-1414.
    PubMed     Abstract available
    
    
    
51. SEKIMOTO T, Grogan A, Kawakami R, Shiraki T, et al
    Plaque fissure and calcified nodule: histopathological findings.
    Eur Heart J. 2026;47:1415-1426.
    PubMed     Abstract available
    
    
    
52. 
    Correction to: Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Eur Heart J. 2026 Mar 12:ehag167. doi: 10.1093.
    PubMed    
    
    
    
53. MA M, Zhang Y, Gao L, Wang Z, et al
    Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization.
    Eur Heart J. 2026;47:1242-1259.
    PubMed     Abstract available
    
    
    
54. PARK DW, Boden WE, De Caterina R, Gallinoro E, et al
    Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques.
    Eur Heart J. 2026 Mar 6:ehag103. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2026
55. PEDICINO D, Liuzzo G
    Weekly Journal Scan: What should we CELEBRATE and what remains uncertain about early platelet inhibition in ST-elevation myocardial infarction.
    Eur Heart J. 2026 Feb 28:ehag125. doi: 10.1093.
    PubMed    
    
    
    
56. ZARAGOZA C
    When RNAs come full circle: new regulators of healing after myocardial infarction.
    Eur Heart J. 2026 Feb 18:ehag038. doi: 10.1093.
    PubMed    
    
    
    
57. ISHII M, Nakamura T, Ikebe S, Otsuka Y, et al
    Air pollution before and during the COVID-19 pandemic: changes in risk of acute myocardial infarction.
    Eur Heart J. 2026 Feb 13:ehag102. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. JUNG M, Schmidt A, Sansonetti M, Al Soodi B, et al
    Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction.
    Eur Heart J. 2026 Feb 11:ehaf1116. doi: 10.1093/eurheartj/ehaf1116.
    PubMed     Abstract available
    
    
    
59. LEE SJ, Lee SJ, Hong SJ, Cho DK, et al
    Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial.
    Eur Heart J. 2026;47:608-621.
    PubMed     Abstract available
    
    
    
60. MINER S, Mejia-Renteria H, Leone AM, Velollari O, et al
    Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study.
    Eur Heart J. 2026;47:594-604.
    PubMed     Abstract available
    
    
    January 2026
61. WEINTRAUB WS, Boden WE
    Does post-surgery cardiology evaluation improve clinical outcome in patients with a peri-operative myocardial infarction?
    Eur Heart J. 2026 Jan 30:ehaf1073. doi: 10.1093/eurheartj/ehaf1073.
    PubMed    
    
    
    
62. GLARNER N, Puelacher C, Gualandro DM, Pargger M, et al
    Peri-operative myocardial infarction/injury after non-cardiac surgery: association between cardiologist evaluation and outcomes.
    Eur Heart J. 2026 Jan 30:ehaf846. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. VERGALLO R, Pedicino D
    Weekly Journal Scan: Complete revascularization in acute myocardial infarction improves major cardiovascular outcomes.
    Eur Heart J. 2026 Jan 30:ehag027. doi: 10.1093.
    PubMed    
    
    
    
64. TEPPO K, Airaksinen KEJ, Vasankari T, Linko-Parvinen A, et al
    Long forms of cardiac troponin T for myocardial infarction diagnosis: the SuperTROPO study.
    Eur Heart J. 2026;47:490-499.
    PubMed     Abstract available
    
    
    
65. SAVONITTO S, Alpert JS, Thiele H, Campo G, et al
    Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.
    Eur Heart J. 2026;47:423-437.
    PubMed     Abstract available
    
    
    
66. VON SCHEIDT M, Adkar SS, Krefting J, Hoermann G, et al
    Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease.
    Eur Heart J. 2026;47:453-469.
    PubMed     Abstract available
    
    
    
67. REHMAN MB, Bjornson E, Adiels M, Morze J, et al
    Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease.
    Eur Heart J. 2026 Jan 22:ehaf1124. doi: 10.1093/eurheartj/ehaf1124.
    PubMed     Abstract available
    
    
    
68. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trial.
    Eur Heart J. 2026 Jan 6:ehaf924. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. GVOZDEVA A, Zakiev V, Ushakova O
    The beneficial effect of heart rate-lowering therapy on mortality in post-myocardial infarction patients across the treatment eras.
    Eur Heart J. 2026 Jan 6:ehaf1052. doi: 10.1093/eurheartj/ehaf1052.
    PubMed    
    
    
    
70. SANIDAS E, Michalopoulou H, Thomopoulos C
    Beta-blockers in post-myocardial infarction patients: refractive errors in reading the evidence.
    Eur Heart J. 2026 Jan 6:ehaf1053. doi: 10.1093/eurheartj/ehaf1053.
    PubMed    
    
    
    December 2025
71. KRALER S, Liberale L, Tirandi A, Moriero M, et al
    The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk.
    Eur Heart J. 2025 Dec 23:ehaf979. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. BERRY C, Stanley B, Duklas P, Layland J, et al
    Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial.
    Eur Heart J. 2025 Dec 8:ehaf925. doi: 10.1093.
    PubMed    
    
    
    
73. VOLLEBERG RHJA, Luttikholt TJ, van der Waerden RGA, Cancian P, et al
    Artificial intelligence-based identification of thin-cap fibroatheromas and clinical outcomes: the PECTUS-AI study.
    Eur Heart J. 2025;46:5032-5041.
    PubMed     Abstract available
    
    
    
74. ANDERSEN MH, Jensen JM, Kanstrup H, Sand NPR, et al
    Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry.
    Eur Heart J. 2025;46:5062-5072.
    PubMed     Abstract available
    
    
    
75. KIRMES K, Han J, Klug M, Bloxham CJ, et al
    Reticulated platelets in coronary artery disease: a multidimensional approach unveils prothrombotic signalling and novel therapeutic targets.
    Eur Heart J. 2025;46:4901-4917.
    PubMed     Abstract available
    
    
    November 2025
76. ZHANG L, Zhang YL, Ding D
    Immune checkpoint inhibitor-associated acute myocardial infarction: a case report.
    Eur Heart J. 2025 Nov 28:ehaf987. doi: 10.1093.
    PubMed    
    
    
    
77. MOHIADDIN H, Sze S, Damluji AA, Ladwiniec A, et al
    Frailty and long-term outcomes in younger patients with acute myocardial infarction.
    Eur Heart J. 2025 Nov 25:ehaf876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. AN KR, Vervoort D, Qiu F, Tam DY, et al
    Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting.
    Eur Heart J. 2025 Nov 25:ehaf806. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. SERRUYS PW, Oshima A, Ferraz-Costa G, Garg S, et al
    Coronary revascularization: a long-term perspective.
    Eur Heart J. 2025 Nov 22:ehaf883. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. PEDICINO D, Volpe M
    Weekly Journal Scan: Reshaping the boundaries of beta-blocker use after acute myocardial infarction beyond reduced ejection fraction?
    Eur Heart J. 2025 Nov 18:ehaf856. doi: 10.1093.
    PubMed    
    
    
    
81. DUNCKER D, Marijon E, Metra M, Piot O, et al
    Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study.
    Eur Heart J. 2025;46:4597-4606.
    PubMed     Abstract available
    
    
    
82. ZHANG B, Yang J, Ge J
    First myocardial infarction: incorporating non-traditional risk factors to bridge the prevention gap.
    Eur Heart J. 2025 Nov 11:ehaf851. doi: 10.1093.
    PubMed    
    
    
    
83. VERGALLO R, Patrono C
    Weekly Journal Scan: Ischaemic vs bleeding risk early after myocardial infarction-which should we TARGET FIRST?
    Eur Heart J. 2025 Nov 11:ehaf893. doi: 10.1093.
    PubMed    
    
    
    
84. NURMOHAMED NS, Bhatt DL
    Preventing the first myocardial infarction: from reaction to action.
    Eur Heart J. 2025 Nov 11:ehaf852. doi: 10.1093.
    PubMed    
    
    
    
85. BOERHOUT CKM, Namba HF, Liu T, Beijk MAM, et al
    Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial.
    Eur Heart J. 2025;46:4396-4406.
    PubMed     Abstract available
    
    
    
86. VAN ZIJVERDEN LM, Thijs A, van Diemen JJK, Wiepjes CM, et al
    Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study.
    Eur Heart J. 2025 Nov 4:ehaf837. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2025
87. AYYAD M, Albandak M, Allencherril J
    Reclassifying myocardial infarction: from ST elevation to coronary occlusion.
    Eur Heart J. 2025 Oct 30:ehaf825. doi: 10.1093.
    PubMed    
    
    
    
88. MONTONE RA, Cosentino N, Gorla R, Biscaglia S, et al
    Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial.
    Eur Heart J. 2025 Oct 28:ehaf917. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. LOMBARDI M, Boivin-Proulx LA, Jeronimo A, Mejia-Renteria H, et al
    Angina after percutaneous coronary interventions.
    Eur Heart J. 2025 Oct 17:ehaf771. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. CREA F
    Ischaemic heart disease: changing landscape of risk stratification, importance of coronary stenosis functional assessment, optimal timing of anticoagulation in ST elevation myocardial infarction.
    Eur Heart J. 2025;46:3799-3804.
    PubMed    
    
    
    
91. ARAI R, Kojima K, Fukamachi D, Okumura Y, et al
    DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry.
    Eur Heart J. 2025 Oct 13:ehaf787. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. VERGALLO R, Pedicino D
    Weekly Journal Scan: An integrated rehabilitation strategy after myocardial infarction in older patients with impaired physical performance.
    Eur Heart J. 2025 Oct 9:ehaf780. doi: 10.1093.
    PubMed    
    
    
    
93. MEENA D, Huang J, Smith A, Yarmolinsky J, et al
    Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study.
    Eur Heart J. 2025 Oct 9:ehaf725. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. DE SILVA R, Cheng K, Henry TD, Perera D, et al
    Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes.
    Eur Heart J. 2025;46:3738-3757.
    PubMed     Abstract available
    
    
    September 2025
95. MUELLER C, White HD, Lopez-Ayala P, de Silva R, et al
    Great debate: the universal definition of myocardial infarction is flawed and should be put to rest.
    Eur Heart J. 2025 Sep 9:ehaf641. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. 
    Correction to: Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
    Eur Heart J. 2025 Sep 8:ehaf708. doi: 10.1093.
    PubMed    
    
    
    
97. GIRAUD MN
    Macrophage leukotriene B4 production sustains inflammation after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf471. doi: 10.1093.
    PubMed    
    
    
    
98. CHEN Z, Song J, Feng S, Liu M, et al
    Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf493. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. AMICONE S, Fedele D, Pizzi C
    Revascularization in latecomer ST-elevation myocardial infarction patients: diverging ACC/AHA and ESC Guidelines.
    Eur Heart J. 2025 Sep 3:ehaf616. doi: 10.1093.
    PubMed    
    
    
    
100. GOULD KL, Johnson NP, Roby AE, Kirkeeide R, et al
     Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.
     Eur Heart J. 2025;46:3273-3286.
     PubMed     Abstract available
     
     
     August 2025
101. KANG DY, Wee SB, Ahn JM, Park H, et al
     Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial.
     Eur Heart J. 2025 Aug 31:ehaf652. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. KINDBORG G, Eriksson Hogling D, Habel H, Yan J, et al
     Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study.
     Eur Heart J. 2025 Aug 31:ehaf677. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. ROSSELLO X, Dominguez-Rodriguez A, Latini R, Sanchez PL, et al
     Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
     Eur Heart J. 2025 Aug 30:ehaf673. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. DILLINGER JG, Pezel T, Batias L, Angoulvant D, et al
     Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial.
     Eur Heart J. 2025 Aug 30:ehaf680. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. WENZL FA, Wang P, Kahles F, Beck KR, et al
     Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.
     Eur Heart J. 2025 Aug 30:ehaf661. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. KAWAGUCHI N, Ando R, Obata J
     A case of cardiopulmonary arrest on arrival due to acute myocardial infarction with immunoglobulin G4-related coronary periarteritis.
     Eur Heart J. 2025 Aug 29:ehaf632. doi: 10.1093.
     PubMed    
     
     
     
107. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
     Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
     Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. LI F, Flynn E, Ha P, Zebak MN, et al
     LIPA, a risk locus for coronary artery disease: decoding the variant-to-function relationship.
     Eur Heart J. 2025 Aug 19:ehaf581. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. KRALER S, Mueller C, Libby P, Bhatt DL, et al
     Acute coronary syndromes: mechanisms, challenges, and new opportunities.
     Eur Heart J. 2025;46:2866-2889.
     PubMed     Abstract available
     
     
     
110. CHEN J, Xu C, Qiu L, Li B, et al
     Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
     Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2025
111. 
     Correction to: Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
     Eur Heart J. 2025 Jul 31:ehaf579. doi: 10.1093.
     PubMed    
     
     
     
112. PARADIES V, Masiero G, Rubboli A, Van Beusekom HMM, et al
     Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
     Eur Heart J. 2025;46:2730-2741.
     PubMed     Abstract available
     
     
     
113. MORZE J, Melloni GEM, Wittenbecher C, Ala-Korpela M, et al
     ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease.
     Eur Heart J. 2025;46:2691-2701.
     PubMed     Abstract available
     
     
     
114. 
     Correction to: Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
     Eur Heart J. 2025 Jul 10:ehaf510. doi: 10.1093.
     PubMed    
     
     
     
115. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
     Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
     Eur Heart J. 2025;46:2498-2519.
     PubMed     Abstract available
     
     
     
116. NURMOHAMED NS, Ngo-Metzger Q, Taub PR, Ray KK, et al
     First myocardial infarction: risk factors, symptoms, and medical therapy.
     Eur Heart J. 2025 Jul 3:ehaf390. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2025
117. MILLER RJH, Yi J, Shanbhag A, Marcinkiewicz A, et al
     Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study.
     Eur Heart J. 2025;46:2336-2347.
     PubMed     Abstract available
     
     
     
118. WANG S, Luo X, Hu S, Zhao C, et al
     Plaque erosion risk and JAK2 V617F variant.
     Eur Heart J. 2025;46:2205-2219.
     PubMed     Abstract available
     
     
     
119. WANG X, Xu Y, Yu C, Deng R, et al
     Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils.
     Eur Heart J. 2025;46:2223-2238.
     PubMed     Abstract available
     
     
     
120. TOVAL A, Bakker EA, Granada-Maia JB, Nunez de Arenas-Arroyo S, et al
     Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis.
     Eur Heart J. 2025;46:2186-2201.
     PubMed     Abstract available
     
     
     
121. ZEDER K, Mak S, Galie N, Rosenkranz S, et al
     Right heart catheterization in heart failure: indications, interpretation, and pitfalls.
     Eur Heart J. 2025 Jun 16:ehaf322. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. HASSAN IN, Ashraf H, Hasan A
     Sudan conflict: impact on interrupted care after acute myocardial infarction.
     Eur Heart J. 2025 Jun 12:ehaf313. doi: 10.1093.
     PubMed    
     
     
     
123. ARENAS-MONTES J, Alcala-Diaz JF, Garcia-Fernandez H, Gutierrez-Mariscal FM, et al
     A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study.
     Eur Heart J. 2025;46:2104-2115.
     PubMed     Abstract available
     
     
     
124. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
     Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
     Eur Heart J. 2025;46:2052-2062.
     PubMed     Abstract available
     
     
     
125. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
     Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
     Eur Heart J. 2025;46:2092-2100.
     PubMed     Abstract available
     
     
     
126. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
     Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
     Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2025
127. KIM MC, Park SJ, Park DW, Ahn JM, et al
     Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
     Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al
     Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
     Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. CLELAND JGF
     Staring into the AbetaYSS: how many pills and for how long after myocardial infarction?
     Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093.
     PubMed    
     
     
     
130. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
     Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
     Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. COYLE M, McEvoy JW
     Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction.
     Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
     PubMed    
     
     
     
132. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
     SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
     Eur Heart J. 2025;46:1747-1762.
     PubMed     Abstract available
     
     
     
133. PERRY CGR, Sweeney G
     Targeting mitochondrial fission for the treatment of myocardial infarction.
     Eur Heart J. 2025 May 6:ehaf296. doi: 10.1093.
     PubMed    
     
     
     
134. OIKONOMOU G, Cheng K, Mohiaddin RH
     CMR: a gatekeeper before ICA in a stable non ST-elevation myocardial infarction patient with severely impaired LV function.
     Eur Heart J. 2025 May 6:ehaf300. doi: 10.1093.
     PubMed    
     
     
     
135. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
     Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
     Eur Heart J. 2025;46:1586-1599.
     PubMed     Abstract available
     
     
     
136. WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al
     Mosaic loss of Y chromosome and mortality after coronary angiography.
     Eur Heart J. 2025;46:1603-1616.
     PubMed     Abstract available
     
     
     
137. ZHANG Q, Li H, Zhuang T, Xu L, et al
     CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
     Eur Heart J. 2025;46:1645-1658.
     PubMed     Abstract available
     
     
     
138. D'ENTREMONT MA, Poorthuis MHF, Fiolet ATL, Amarenco P, et al
     Colchicine for secondary prevention of vascular events: a meta-analysis of trials.
     Eur Heart J. 2025 May 2:ehaf210. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. SAMUEL M, Berry C, Dube MP, Koenig W, et al
     Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.
     Eur Heart J. 2025 May 2:ehaf174. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2025
140. CREA F
     Focus on heart failure: sex-related differences, new light shed on SGLT2i mechanism of action, and heart failure after myocardial infarction.
     Eur Heart J. 2025;46:1457-1461.
     PubMed    
     
     
     
141. MOLLER JE, Thiele H, Morrow D, Kjaergaard J, et al
     Mechanical circulatory support: when, how, and for whom.
     Eur Heart J. 2025;46:1480-1492.
     PubMed     Abstract available
     
     
     
142. CHEN J, Zhao J, Fu S
     Addressing sample overlap and meta-analysis imbalances in Mendelian randomization: a critical appraisal of protein targets for myocardial infarction.
     Eur Heart J. 2025 Apr 18:ehaf186. doi: 10.1093.
     PubMed    
     
     
     
143. TITOVA OE, Yuan S, Larsson SC
     Applying Mendelian randomization to study the relationship between circulating proteins and myocardial infarction.
     Eur Heart J. 2025 Apr 18:ehaf187. doi: 10.1093.
     PubMed    
     
     
     
144. BAY B, Tanner R, Gao M, Oliva A, et al
     Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
     Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. BOUGHANEM H, Herrero-Cervera A, Soehnlein O
     SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair.
     Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093.
     PubMed    
     
     
     March 2025
146. BUSCHER A, Plagwitz L, Yildirim K, Brix TJ, et al
     Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department.
     Eur Heart J. 2025 Mar 29:ehaf254. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. CHIU IM, Ouyang D
     Acute myocardial infarction diagnosis: impact of artificial intelligence-powered ECG interpretation.
     Eur Heart J. 2025 Mar 25:ehaf142. doi: 10.1093.
     PubMed    
     
     
     
148. SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al
     Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes.
     Eur Heart J. 2025;46:1112-1123.
     PubMed     Abstract available
     
     
     
149. XU Y, Feng T, Huang Y
     Gender-specific associations and circulating proteins in myocardial infarction: potential causal relationships.
     Eur Heart J. 2025 Mar 7:ehaf111. doi: 10.1093.
     PubMed    
     
     
     
150. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
     Circulating proteins and incident myocardial infarction: appraising sex-specific differences and causality.
     Eur Heart J. 2025 Mar 7:ehaf113. doi: 10.1093.
     PubMed    
     
     
     
151. BOUZID Z, Sejdic E, Martin-Gill C, Faramand Z, et al
     Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome.
     Eur Heart J. 2025;46:943-954.
     PubMed     Abstract available
     
     
     
152. CLAESSEN G, Eijsvogels TMH, Albert CM, Baggish AL, et al
     Coronary atherosclerosis in athletes: emerging concepts and preventive strategies.
     Eur Heart J. 2025;46:890-903.
     PubMed     Abstract available
     
     
     
153. CALAFIORE AM, Prapas S, Gaudino M
     Arterial conduits for coronary bypass grafting: the set-point concept.
     Eur Heart J. 2025;46:922-925.
     PubMed     Abstract available
     
     
     
154. DANG QM, Psaltis PJ, Burgess S, Chandrasekhar J, et al
     The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.
     Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2025
155. LEE MS, Shin TG, Lee Y, Kim DH, et al
     Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study.
     Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. CHEN G, Gan J, Wu F, Zhou Z, et al
     Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
     Eur Heart J. 2025 Feb 11:ehaf032. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. SQUIRE IB, Sze S
     Prognosis following acute myocardial infarction.
     Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093.
     PubMed    
     
     
     
158. ROMAN M, Miksza J, Lai FY, Sze S, et al
     Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
     Eur Heart J. 2025;46:535-547.
     PubMed     Abstract available
     
     
     
159. CREA F
     Focus on the extreme of the spectrum: myocardial infarction with no obstructive coronary arteries and ischaemic cardiomyopathy.
     Eur Heart J. 2025;46:399-403.
     PubMed    
     
     
     
160. RASMUSSEN LD, Schmidt SE, Knuuti J, Vrints C, et al
     Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
     Eur Heart J. 2025;46:473-483.
     PubMed     Abstract available
     
     
     
161. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
     Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
     Eur Heart J. 2025;46:424-435.
     PubMed     Abstract available
     
     
     January 2025
162. BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al
     Incident heart failure and recurrent coronary events following acute myocardial infarction.
     Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. PEDICINO D, Volpe M
     Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone in acute myocardial infarction.
     Eur Heart J. 2025 Jan 21:ehae936. doi: 10.1093.
     PubMed    
     
     
     
164. REEH J, Afzal S, Wulff AB, Nordestgaard BG, et al
     Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years.
     Eur Heart J. 2025 Jan 17:ehae912. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. LIUZZO G, Patrono C
     Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction.
     Eur Heart J. 2025 Jan 9:ehae897. doi: 10.1093.
     PubMed    
     
     
     
166. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
     Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
     Eur Heart J. 2025;46:190-214.
     PubMed     Abstract available
     
     
     
167. BJERKING LH, Skak-Hansen KW, Heitmann M, Hove JD, et al
     Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
     Eur Heart J. 2025;46:117-128.
     PubMed     Abstract available
     
     
     
168. WENZL FA, Wang P, Arrigo M, Parenica J, et al
     Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score.
     Eur Heart J. 2025;46:38-54.
     PubMed     Abstract available
     
     
     December 2024
169. ZHANG Y, Yu S, Chen Z, Liu H, et al
     Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data.
     Eur Heart J. 2024;45:5156-5167.
     PubMed     Abstract available
     
     
     
170. PEDICINO D, Volpe M
     Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial.
     Eur Heart J. 2024 Dec 14:ehae858. doi: 10.1093.
     PubMed    
     
     
     
171. CHAPMAN AR, Taggart C, Boeddinghaus J, Mills NL, et al
     Type 2 myocardial infarction: challenges in diagnosis and treatment.
     Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2024
172. BACK M, Hofmann R
     Myocardial infarction and low ambient temperature: does presence or absence of stenoses make a difference?
     Eur Heart J. 2024 Nov 28:ehae820. doi: 10.1093.
     PubMed    
     
     
     
173. AI L, de Freitas Germano J, Huang C, Aniag M, et al
     Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.
     Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093.
     PubMed     Abstract available
     
     
     
174. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
     Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
     Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. NARAYANAN S, Vuckovic S, Bergman O, Wirka R, et al
     Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
     Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093.
     PubMed     Abstract available
     
     
     
176. BENDRISS E, Pasqueron J, Bardon J
     Coronary air embolism causing myocardial infarction following a blunt chest trauma.
     Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093.
     PubMed    
     
     
     
177. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
     Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
     Eur Heart J. 2024;45:4564-4578.
     PubMed     Abstract available
     
     
     
178. ZURIAGA MA, Yu Z, Matesanz N, Truong B, et al
     Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis.
     Eur Heart J. 2024;45:4601-4615.
     PubMed     Abstract available
     
     
     
179. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
     Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
     Eur Heart J. 2024;45:4630-4643.
     PubMed     Abstract available
     
     
     October 2024
180. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
     Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
     Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. HUANG J, He Q, Jiang Y, Wong JMJ, et al
     Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide study.
     Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093.
     PubMed     Abstract available
     
     
     
182. KANG D, Choi KH, Kim H, Park H, et al
     Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
     Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
     PubMed     Abstract available
     
     
     
183. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
     Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
     Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
     Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
     Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
     PubMed    
     
     
     
185. LIUZZO G, Patrono C
     Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
     Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093.
     PubMed    
     
     
     
186. RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al
     Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
     Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. CREA F
     Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets.
     Eur Heart J. 2024;45:4141-4144.
     PubMed    
     
     
     
188. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
     Plasma proteome and incident myocardial infarction: sex-specific differences.
     Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093.
     PubMed     Abstract available
     
     
     
189. BARTON AK, Lau ES, Gulati M
     Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction.
     Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093.
     PubMed    
     
     
     
190. DESCH S, Zeymer U, Akin I, Behnes M, et al
     Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
     Eur Heart J. 2024;45:4200-4203.
     PubMed    
     
     
     
191. WEINTRAUB WS, Boden WE
     Achieving successful prevention of coronary artery disease: a worldwide call to action.
     Eur Heart J. 2024;45:4197-4199.
     PubMed    
     
     
     
192. LUSEBRINK E, Binzenhofer L, Thiele H
     The DanGer Shock trial: a new dawn but much to uncover.
     Eur Heart J. 2024;45:4181-4183.
     PubMed    
     
     
     
193. LUSCHER TF, Thiele H
     Cardiogenic shock: do we need a paradigm shift?
     Eur Heart J. 2024;45:4178-4180.
     PubMed    
     
     
     
194. 
     Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
     Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
     PubMed    
     
     
     
195. AJUFO EC, Tedrow UB
     Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.
     Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093.
     PubMed    
     
     
     
196. PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al
     Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
     Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. SHIMADA T, Fujisawa N, Otsuka K
     Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
     Eur Heart J. 2024;45:3894.
     PubMed    
     
     
     September 2024
198. XU Y, Li H, Santosa A, Wettermark B, et al
     Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
     Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. CREA F
     New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
     Eur Heart J. 2024;45:3299-3302.
     PubMed    
     
     
     
200. BAIREY MERZ CN
     Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
     Eur Heart J. 2024;45:3748-3750.
     PubMed    
     
     
     
201. BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al
     Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
     Eur Heart J. 2024;45:3701-3706.
     PubMed     Abstract available
     
     
     
202. VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al
     2024 ESC Guidelines for the management of chronic coronary syndromes.
     Eur Heart J. 2024;45:3415-3537.
     PubMed    
     
     
     
203. NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al
     Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
     Eur Heart J. 2024;45:3735-3747.
     PubMed     Abstract available
     
     
     
204. VERGALLO R, Liuzzo G
     Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease.
     Eur Heart J. 2024;45:3311-3313.
     PubMed    
     
     
     
205. PEDICINO D, Volpe M
     Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection.
     Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093.
     PubMed    
     
     
     
206. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
     Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
     Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
     PubMed     Abstract available
     
     
     
207. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
     Great debate: myocardial infarction after cardiac surgery must be redefined.
     Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
     PubMed    
     
     
     
208. BADIMON L, Kiss A, Podesser BK
     Spleen in action for cardioprotection.
     Eur Heart J. 2024;45:3178-3180.
     PubMed    
     
     
     
209. NISHI T, Kume T, Saito Y, Kato K, et al
     Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in patients with non-obstructive coronary artery disease.
     Eur Heart J. 2024;45:3181-3183.
     PubMed    
     
     
     
210. LIUZZO G, Patrono C
     Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
     Eur Heart J. 2024;45:3108-3110.
     PubMed    
     
     
     
211. LIEDER HR, Paket U, Skyschally A, Rink AD, et al
     Vago-splenic signal transduction of cardioprotection in humans.
     Eur Heart J. 2024;45:3164-3177.
     PubMed     Abstract available
     
     
     
212. GIBSON CM, Duffy D, Bahit MC, Chi G, et al
     Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
     Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093.
     PubMed     Abstract available
     
     
     
213. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
     Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
     Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
     PubMed     Abstract available
     
     
     
214. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
     Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
     Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
     PubMed     Abstract available
     
     
     
215. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
     Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
     Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
     PubMed     Abstract available
     
     
     
216. EITEL I, Saraei R, Jurczyk D, Fach A, et al
     Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
     Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
     PubMed     Abstract available
     
     
     
217. SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al
     Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
     Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093.
     PubMed     Abstract available
     
     
     
218. VAN DEN BROEK WWA, Ten Berg JM
     The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
     Eur Heart J. 2024;45:3057-3059.
     PubMed    
     
     
     
219. PRENDERGAST BD, Patterson T, Redwood S
     Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
     Eur Heart J. 2024;45:3042-3044.
     PubMed    
     
     
     August 2024
220. ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al
     Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
     Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093.
     PubMed    
     
     
     
221. GERHARDT T, Landmesser U
     Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary extracellular vesicles of myocardial infarction patients.
     Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093.
     PubMed    
     
     
     
222. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
     Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
     Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. 
     Correction to: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093.
     PubMed    
     
     
     
224. MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al
     Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
     Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093.
     PubMed     Abstract available
     
     
     
225. TARDIF JC, Ouellette K, Boulet J
     Colchicine improves outcomes in coronary disease, but will it in heart failure?
     Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093.
     PubMed    
     
     
     
226. MAHAFFEY KW, Tuttle KR, Arici M, Baeres FMM, et al
     Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
     Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093.
     PubMed     Abstract available
     
     
     
227. CREA F
     Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
     Eur Heart J. 2024;45:2795-2799.
     PubMed    
     
     
     
228. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
     Coronary artery disease management in older adults: revascularization and exercise training.
     Eur Heart J. 2024;45:2811-2823.
     PubMed     Abstract available
     
     
     
229. CREA F
     Heart failure and ischaemic heart disease: new challenges and opportunities.
     Eur Heart J. 2024;45:2681-2685.
     PubMed    
     
     
     
230. BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al
     Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
     Eur Heart J. 2024;45:2785-2788.
     PubMed    
     
     
     
231. VOLLEBERG R, Damman P, van Royen N
     Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography.
     Eur Heart J. 2024;45:2793.
     PubMed    
     
     
     
232. CIULLO A, Li L, Li C, Tsi K, et al
     Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism.
     Eur Heart J. 2024;45:2660-2673.
     PubMed     Abstract available
     
     
     
233. PEDICINO D, Vergallo R
     Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
     Eur Heart J. 2024;45:2592-2593.
     PubMed    
     
     
     July 2024
234. LIUZZO G, Patrono C
     Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction.
     Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093.
     PubMed    
     
     
     
235. BESOLA L, Colli A, De Caterina R
     Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
     Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
     PubMed     Abstract available
     
     
     
236. KANG J, Yun J, Park KW, Park M, et al
     Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
     Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
     PubMed     Abstract available
     
     
     
237. CREA F
     Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
     Eur Heart J. 2024;45:2463-2467.
     PubMed    
     
     
     
238. GIANNITSIS E, Frey N, Katus HA
     Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
     Eur Heart J. 2024;45:2516-2518.
     PubMed    
     
     
     
239. DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al
     Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of female and male patients with coronary artery disease.
     Eur Heart J. 2024;45:2468-2470.
     PubMed    
     
     
     
240. AHMAD Y, Lansky AJ
     Periprocedural myocardial infarction: thresholds of (in)significance.
     Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
     PubMed    
     
     
     
241. JURADO-ROMAN A, Agudo-Quilez P
     Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
     Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
     PubMed    
     
     
     
242. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
     Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
     PubMed     Abstract available
     
     
     
243. FIGTREE GA, Gray MP
     Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
     Eur Heart J. 2024;45:2407-2409.
     PubMed    
     
     
     
244. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
     Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
     Eur Heart J. 2024;45:2396-2406.
     PubMed     Abstract available
     
     
     
245. BEKKI M, Tahara N, Fukumoto Y
     Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
     Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
     PubMed    
     
     
     June 2024
246. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
     Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
     Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
     PubMed     Abstract available
     
     
     
247. VILAHUR G, Radike M, Badimon L
     Novel cardioprotective approaches in ischaemic heart disease.
     Eur Heart J. 2024;45:2109-2111.
     PubMed    
     
     
     
248. HOLFELD J, Nagele F, Polzl L, Engler C, et al
     Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
     Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
249. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
     Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
     Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
     PubMed     Abstract available
     
     
     
250. PEDICINO D, Volpe M
     Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
     Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
     PubMed    
     
     
     
251. COUGHLAN JJ, Durand R, Byrne RA
     An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
     Eur Heart J. 2024;45:2063-2065.
     PubMed    
     
     
     
252. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
     Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
     Eur Heart J. 2024;45:2052-2062.
     PubMed     Abstract available
     
     
     
253. BEERKENS FJ, Bhatt DL
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
     Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
     PubMed    
     
     
     
254. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
     Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
     Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
     PubMed     Abstract available
     
     
     
255. LIUZZO G, Patrono C
     Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
     Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
     PubMed    
     
     
     
256. VERGALLO R, Pedicino D
     Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
     Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
     PubMed    
     
     
     
257. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
     How artificial intelligence can assist with ischaemic heart disease.
     Eur Heart J. 2024;45:1866-1868.
     PubMed    
     
     
     May 2024
258. REN J, Bowyer A, Tian DH, Royse C, et al
     Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
     Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
     PubMed     Abstract available
     
     
     
259. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
     Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
260. KWON O, Ahn JH, Koh JS, Park Y, et al
     Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
     Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
     PubMed     Abstract available
     
     
     
261. CREA F
     The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
     Eur Heart J. 2024;45:1769-1773.
     PubMed    
     
     
     
262. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
     Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
     Eur Heart J. 2024;45:1783-1800.
     PubMed     Abstract available
     
     
     
263. HARIK L, Gaudino M
     Coronary angiography and bypass surgery: born together and now going separate ways?
     Eur Heart J. 2024;45:1816-1818.
     PubMed    
     
     
     
264. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
     Coronary bypass surgery guided by computed tomography in a low-risk population.
     Eur Heart J. 2024;45:1804-1815.
     PubMed     Abstract available
     
     
     
265. LEE YJ, Shin S, Kwon SW, Suh Y, et al
     Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
     Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
     PubMed     Abstract available
     
     
     
266. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
267. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
     Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
     Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
268. CREA F
     Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
     Eur Heart J. 2024;45:1577-1581.
     PubMed    
     
     
     
269. TAKAHARA M, Soga Y, Iida O
     Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
     Eur Heart J. 2024;45:1634-1643.
     PubMed     Abstract available
     
     
     
270. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
     Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
     Eur Heart J. 2024;45:1681-1683.
     PubMed    
     
     
     
271. YANG K, Gao R, Chen H, Hu J, et al
     Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
     Eur Heart J. 2024;45:1662-1680.
     PubMed     Abstract available
     
     
     
272. ADLAM D, van Dijk FS, Loeys B
     Genetic testing in patients with unexplained coronary aneurysms or dilation.
     Eur Heart J. 2024;45:1610-1612.
     PubMed    
     
     
     
273. JONES DA, Beirne AM, Kelham M, Wynne L, et al
     Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
     Eur Heart J. 2024;45:1647-1658.
     PubMed     Abstract available
     
     
     
274. XIAO Q, Xu Y, Wang S
     Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
     Eur Heart J. 2024;45:1685.
     PubMed    
     
     
     
275. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
     Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
     Eur Heart J. 2024;45:1540-1549.
     PubMed     Abstract available
     
     
     
276. HEUSCH G, Kleinbongard P
     Cardioprotection research has left its comfort zone.
     Eur Heart J. 2024;45:1568-1570.
     PubMed    
     
     
     
277. VERGALLO R, Patrono C
     Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
     Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
     PubMed    
     
     
     April 2024
278. NGO LTH, Peng Y, Denman R, Yang I, et al
     Long-term outcomes after hospitalization for atrial fibrillation or flutter.
     Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
     PubMed     Abstract available
     
     
     
279. GALIUTO L, Volpe M
     Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
     Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
     PubMed    
     
     
     
280. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
     Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
     Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
     PubMed    
     
     
     
281. VERGALLO R, Galiuto L
     Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
     Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
     PubMed    
     
     
     
282. CREA F
     The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
     Eur Heart J. 2024;45:1183-1187.
     PubMed    
     
     
     
283. KASKI JC, Al-Lamee R, Boden WE
     The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
     Eur Heart J. 2024;45:1201-1204.
     PubMed    
     
     
     
284. AMERI P, Bertero E, Lombardi M, Porto I, et al
     Ischaemic heart disease in patients with cancer.
     Eur Heart J. 2024;45:1209-1223.
     PubMed     Abstract available
     
     
     
285. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
     The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
     Eur Heart J. 2024;45:1193-1195.
     PubMed    
     
     
     
286. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
     Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
     Eur Heart J. 2024;45:1285.
     PubMed    
     
     
     
287. WU VC, Yeh JK, Chen SW, Wu CL, et al
     Syphilis and cardiovascular risk: a Taiwanese registry.
     Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
     PubMed     Abstract available
     
     
     
288. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
     Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
     Eur Heart J. 2024;45:1173-1176.
     PubMed    
     
     
     March 2024
289. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
     Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
     Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
290. WYLD M, Webster AC
     Myocardial infarction and stroke in patients with kidney failure: can we do better?
     Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
     PubMed    
     
     
     
291. TSUDA K, Nagamatsu W, Morii I
     A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
     Eur Heart J. 2024;45:1087.
     PubMed    
     
     
     
292. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
     Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
     Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
     PubMed     Abstract available
     
     
     
293. URSO S, Sadaba R, Dayan V
     Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
     Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
     PubMed    
     
     
     
294. VERGALLO R, Galiuto L
     Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
     Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
     PubMed    
     
     
     
295. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
     Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
     Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
     PubMed     Abstract available
     
     
     
296. CREA F
     Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
     Eur Heart J. 2024;45:637-641.
     PubMed    
     
     
     
297. JANSEN TPJ, Wentzel JJ, Damman P
     Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
     Eur Heart J. 2024;45:737.
     PubMed    
     
     
     February 2024
298. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
     Human papillomavirus infection and cardiovascular mortality: a cohort study.
     Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
     PubMed     Abstract available
     
     
     
299. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2024
300. SENIOR R, Khattar RS
     To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
     Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
     PubMed    
     
     
     
301. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
     Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
302. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
     Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
     Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
     PubMed     Abstract available
     
     
     
303. LI Z, Zhang H, Lin S
     Functionally bicuspid aortic valve leads to myocardial ischaemia.
     Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
     PubMed    
     
     
     December 2023
304. PIRIOU PG, Plessis J, Guerin P
     Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
     Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
     PubMed    
     
     
     November 2023
305. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     
306. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
     Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
     Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
     PubMed     Abstract available
     
     
     
307. KIM H, Kang DY, Lee J, Choi Y, et al
     Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
     Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum